- Home
- SIGA
as of 12-12-2025 3:41pm EST
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 421.8M | IPO Year: | 1997 |
| Target Price: | N/A | AVG Volume (30 days): | 368.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Annual | |
| EPS: | 1.03 | EPS Growth: | -13.82 |
| 52 Week Low/High: | $4.95 - $9.62 | Next Earning Date: | 11-06-2025 |
| Revenue: | $172,249,641 | Revenue Growth: | -0.85% |
| Revenue Growth (this year): | -28.31% | Revenue Growth (next year): | 132.36% |
AI-Powered SIGA Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare SIGA vs Leading Stocks
See how SIGA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SIGA SIGA Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.